Industry & Trade Pfizer to buy antibiotics business from AstraZeneca Noha Gad Aug 25, 2016 0 Pharmaceutical company AstraZeneca (AZN.L) has agreed to sell its small molecule antibiotics business to Pfizer Inc…
Industry & Trade AstraZeneca earnings hit by waning cholesterol drug sales Noha Gad Jul 28, 2016 0 Generic competition to cholesterol buster Crestor in the U.S. market pushed second-quarter earnings down by nearly…
Industry & Trade AstraZeneca’s Zavicefta treatment approved in EU Yomna Yasser Jun 28, 2016 0 AstraZeneca PLC announced Tuesday that the European Commission has approved the use of its infection treatment…
Industry & Trade AstraZeneca’s Zavicefta treatment approved in EU Yomna Yasser Jun 28, 2016 0 AstraZeneca PLC announced Tuesday that the European Commission has approved the use of its infection treatment…
unclassified AstraZeneca boosted by good results for biotech asthma drug Noha Gad May 17, 2016 0 AstraZeneca's (AZN.L) drive to rebuild its portfolio of new medicines received a boost on Tuesday with positive…
Industry & Trade AstraZeneca boosted by good results for biotech asthma drug Noha Gad May 17, 2016 0 AstraZeneca's (AZN.L) drive to rebuild its portfolio of new medicines received a boost on Tuesday with positive…
Industry & Trade AstraZeneca sells rare cancer drug to Sanofi for up to $300mn Yomna Yasser Jul 27, 2015 0 AstraZeneca (AZN.L), under pressure from falling sales of older drugs, is selling a medicine for a rare type of…
Industry & Trade AstraZeneca Forecasts Revenue of $45bn by 2023 Yomna Yasser Nov 18, 2014 0 U.K.-listed pharmaceutical company AstraZeneca PLC on Tuesday said its pipeline of drugs is expected to drive…
Industry & Trade AstraZeneca Strengthens Cancer Business with New Deals Yomna Yasser Nov 4, 2014 0 AstraZeneca moved to strengthen its core oncology business on Tuesday with three deals designed to expand the…
Industry & Trade Pfizer Beats Sales and Profit Forecasts, Mum on Future Deals Yomna Yasser Oct 29, 2014 0 Pfizer Inc (PFE.N) reported stronger-than-expected quarterly results, helped by growing sales of its cancer drugs…